We have conducted exhaustive research on the contents of LivLong and have listed some of the research information below.
LivLong and COPD - http://ajrccm.atsjournals.org/cgi/content/full/179/7/566
LivLong and Disease - http://the-scientist.com/2012/05/01/...es-in-disease/
Astragoloside IV and Colitis - http://www.ncbi.nlm.nih.gov/pubmed/19539495
Astragoloside IV and Parkinson's - http://www.ncbi.nlm.nih.gov/pubmed/22278385
Effect of Astragalus Extract On the Immune System - http://www.nutralegacy.com/blog/general-healthcare/4-positive-effects-of-astragalus-extract-on-immune-system/
Astralagus, Astragoloside IV and Chronic Inflammation http://www.vincegiuliano.com/Antiagingfirewalls.htm#
Astralagus acts as a Firewall to Chronic Inflammation and Cancer http://www.mskcc.org/cancer-care/herb/astragalus
Lung Function - Read the last paragraph http://www.rechargebiomedical.com/blog/biomarkers/for-death-begins-with-lifes-first-breath/
Astragoloside IV and Diabetes - http://www.latest-science-articles.com/Medical_health/A-Model-for-ARI-Screening-and-Effect-of-Astragaloside-IV-on-Growth-of-VSMC-and-I-26779.html
Astragoloside IV and Heart Failure - http://www.cmjournal.org/content/4/1/6
Cycloastragenol - The pharmacology and pharmacokinetics of cycloastragenol have recently (as of 2010) become a newsworthy item due to their ability to up-regulate telomerase in cells, the first known agent to do so. Cycloastragenol also has lymphocyte-modulating properties due to the telomerase altering property. Cell senescence in most human cells (other than progressed cancerous cells and some reproductive cells) occurs after 75-100 divisions, a phenomenon known as the Hayflick limit. When a human is first conceived, the length of the telomeres averages about 15,000 bases (up to 2,500 TTAGGG repeat units) as measured by a process called terminal restriction fragment length analysis. The length then begins to decrease at a rate of about 100 bases per cell division. By the time a person is born, the average telomere length has already dwindled to about 10,000 bases and then throughout the rest of a person’s lifetime the average length of the telomeres gradually decreases to about 5,000 bases at which time the person’s cells lose the ability to divide. These cells are then senescent, and the person suffers and dies of old age. All normal human somatic cells have a finite number of times that they can divide and when this limit is reached cells are described as cellular senescent. There are various nutraceuticals that claim to both increase the health of individuals and delay the onset of cellular aging. The nutraceuticals resveratrol and cycloastragenol known for their ability to enhance T cell functions in vitro were studied. In this study the effect of these compounds on cellular proliferative capacity, These preliminary results suggest that nutraceuticals inhibit the onset aging
**THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.
We recommend that you should consult with your own physicians if you have an autoimmune disease before taking this supplement.
Precautions: At recommended doses, astragalus has no serious side effects and can generally be used safely. It does interact with other herbs and medications (see Possible Interactions section). If you are pregnant or breast-feeding, you should talk to your doctor before taking any medication, including herbs.
Possible Interactions: If you are being treated with any of the following medications, you should not use astragalus without first talking to your health care provider: Drugs that suppress the immune system -- Astragalus may counteract the immune-suppressing effects of cyclophosphamide, a medication used to reduce the chances of rejection in transplant recipients, as well as corticosteroids.